Project Details
Description
Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones
Description
Preparation and implementation of a clinical trial endTB-Q which relates to testing novel regimes to treat MDR-TB resistant to fluoroquinilones
| Acronym | EndTB O5 |
|---|---|
| Status | Finished |
| Effective start/end date | 1/07/20 → 30/06/25 |
Funding
- MSF France: €969,047.49
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.